The global hemostasis analyzers market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of cardiovascular diseases and cancer, which are major causes for blood clotting. The increasing number of patients suffering from these diseases will drive the demand for hemostasis analyzers in the coming years. The fully automated hemostasis analyzers segment accounted for a significant share in 2018 and is expected to continue its dominance throughout the forecast period due to their high accuracy and precision levels. These devices are also easy-to-use and require less time than semiautomated devices, which makes them more popular among healthcare providers as well as patients. Hemostasis Analyzers Market by Type (Fully Automated Hemostasis Analyzers, Semautomated Hemostasis Analyzers), By Application (Hospitals, Research Institutes, Diagnostic Centers) And By Region (North America, Latin America, Europe, Asia Pacific And Middle East & Africa) - Forecast From 2021 To 2030.
- Increasing prevalence of cardiovascular diseases and cancer are the major factors driving the growth of the Hemostasis Analyzers market.
- Increasing demand for point-of-care testing devices is also driving the growth of this market.
- The increasing number of research and development activities in this field is also expected to fuel the growth of this market.
- Lack of skilled professionals in this field is a major factor restraining the growth.
Industry Growth Insights published a new data on “Hemostasis Analyzers Market”. The research report is titled “Hemostasis Analyzers Market research by Types (Fully Automated Hemostasis Analyzers, Semi-automated Hemostasis Analyzers), By Applications (Hospitals, Research Institutes, Diagnostic Centers, Others), By Players/Companies Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Instrumentation Laboratory (Werfen), International Technidyne Corporation (ITC)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hemostasis Analyzers Market Research Report
By Type
Fully Automated Hemostasis Analyzers, Semi-automated Hemostasis Analyzers
By Application
Hospitals, Research Institutes, Diagnostic Centers, Others
By Companies
Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Instrumentation Laboratory (Werfen), International Technidyne Corporation (ITC)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Hemostasis Analyzers Market Report Segments:
The global Hemostasis Analyzers market is segmented on the basis of:
Types
Fully Automated Hemostasis Analyzers, Semi-automated Hemostasis Analyzers
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Research Institutes, Diagnostic Centers, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stago Group (HemoSonics)
- Grifols
- Haemonetics
- Roche Diagnostics
- Abbott (Alere)
- Sysmex Corporation
- Nihon Kohden
- Thermo Fisher Scientific
- Siemens
- Helena Laboratories
- Instrumentation Laboratory (Werfen)
- International Technidyne Corporation (ITC)
Highlights of The Hemostasis Analyzers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Fully Automated Hemostasis Analyzers
- Semi-automated Hemostasis Analyzers
- By Application:
- Hospitals
- Research Institutes
- Diagnostic Centers
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hemostasis Analyzers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hemostasis analyzers are medical devices that measure the levels of blood clotting factors in a patient's blood. Hemostasis analyzers can help doctors diagnose and treat conditions that cause bleeding, such as stroke, heart attack, or cancer.
Some of the key players operating in the hemostasis analyzers market are Stago Group (HemoSonics), Grifols, Haemonetics, Roche Diagnostics, Abbott (Alere), Sysmex Corporation, Nihon Kohden, Thermo Fisher Scientific, Siemens, Helena Laboratories, Instrumentation Laboratory (Werfen), International Technidyne Corporation (ITC).
The hemostasis analyzers market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Hemostasis Analyzers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Hemostasis Analyzers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Hemostasis Analyzers Market - Supply Chain
4.5. Global Hemostasis Analyzers Market Forecast
4.5.1. Hemostasis Analyzers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Hemostasis Analyzers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Hemostasis Analyzers Market Absolute $ Opportunity
5. Global Hemostasis Analyzers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Hemostasis Analyzers Market Size and Volume Forecast by Type
5.3.1. Fully Automated Hemostasis Analyzers
5.3.2. Semi-automated Hemostasis Analyzers
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Hemostasis Analyzers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Hemostasis Analyzers Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Research Institutes
6.3.3. Diagnostic Centers
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Hemostasis Analyzers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Hemostasis Analyzers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Hemostasis Analyzers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Hemostasis Analyzers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Hemostasis Analyzers Demand Share Forecast, 2019-2026
9. North America Hemostasis Analyzers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Hemostasis Analyzers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Hemostasis Analyzers Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Research Institutes
9.4.3. Diagnostic Centers
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Hemostasis Analyzers Market Size and Volume Forecast by Type
9.7.1. Fully Automated Hemostasis Analyzers
9.7.2. Semi-automated Hemostasis Analyzers
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Hemostasis Analyzers Demand Share Forecast, 2019-2026
10. Latin America Hemostasis Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Hemostasis Analyzers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Hemostasis Analyzers Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Research Institutes
10.4.3. Diagnostic Centers
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Hemostasis Analyzers Market Size and Volume Forecast by Type
10.7.1. Fully Automated Hemostasis Analyzers
10.7.2. Semi-automated Hemostasis Analyzers
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Hemostasis Analyzers Demand Share Forecast, 2019-2026
11. Europe Hemostasis Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Hemostasis Analyzers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Hemostasis Analyzers Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Research Institutes
11.4.3. Diagnostic Centers
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Hemostasis Analyzers Market Size and Volume Forecast by Type
11.7.1. Fully Automated Hemostasis Analyzers
11.7.2. Semi-automated Hemostasis Analyzers
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Hemostasis Analyzers Demand Share, 2019-2026
12. Asia Pacific Hemostasis Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Hemostasis Analyzers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Hemostasis Analyzers Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Research Institutes
12.4.3. Diagnostic Centers
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Hemostasis Analyzers Market Size and Volume Forecast by Type
12.7.1. Fully Automated Hemostasis Analyzers
12.7.2. Semi-automated Hemostasis Analyzers
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Hemostasis Analyzers Demand Share, 2019-2026
13. Middle East & Africa Hemostasis Analyzers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Hemostasis Analyzers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Hemostasis Analyzers Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Research Institutes
13.4.3. Diagnostic Centers
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Hemostasis Analyzers Market Size and Volume Forecast by Type
13.7.1. Fully Automated Hemostasis Analyzers
13.7.2. Semi-automated Hemostasis Analyzers
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Hemostasis Analyzers Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Hemostasis Analyzers Market: Market Share Analysis
14.2. Hemostasis Analyzers Distributors and Customers
14.3. Hemostasis Analyzers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stago Group (HemoSonics)
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Grifols
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Haemonetics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Roche Diagnostics
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Abbott (Alere)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sysmex Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Nihon Kohden
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Thermo Fisher Scientific
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Siemens
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Helena Laboratories
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Instrumentation Laboratory (Werfen)
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. International Technidyne Corporation (ITC)
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook